Compounds > aripiprazole
Page last updated: 2024-08-24

aripiprazole and colforsin

aripiprazole has been researched along with colforsin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burris, KD; Kikuchi, T; Molinoff, PB; Molski, TF; Ryan, E; Tottori, K; Xu, C; Yocca, FD1
Burris, KD; Kikuchi, T; Miwa, T; Mori, T; Stark, A; Tadori, Y; Tottori, K1
Forbes, RA; Kikuchi, T; McQuade, RD; Tadori, Y1
Kikuchi, T; Tadori, Y1

Reviews

1 review(s) available for aripiprazole and colforsin

ArticleYear
[Pharmacology of antipsychotics at human dopamine D2 and D3 receptors].
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2012, Volume: 32, Issue:1

    Topics: Antipsychotic Agents; Aripiprazole; Cells, Cultured; Colforsin; Dopamine D2 Receptor Antagonists; Humans; Piperazines; Quinolones; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia

2012

Other Studies

3 other study(ies) available for aripiprazole and colforsin

ArticleYear
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 302, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Antipsychotic Agents; Aripiprazole; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; GTP-Binding Proteins; Humans; Piperazines; Quinolones; Radioligand Assay; Receptors, Dopamine D2; Signal Transduction; Spiperone

2002
Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic.
    European journal of pharmacology, 2005, May-16, Volume: 515, Issue:1-3

    Topics: Animals; Antipsychotic Agents; Aripiprazole; Binding, Competitive; Cell Membrane; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; DNA, Complementary; Dopamine; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Humans; Lisuride; Piperazines; Piperidines; Quinolones; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Risperidone; Transfection; Tritium

2005
Functional potencies of dopamine agonists and antagonists at human dopamine D₂ and D₃ receptors.
    European journal of pharmacology, 2011, Volume: 666, Issue:1-3

    Topics: Animals; Aripiprazole; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Piperazines; Quinolones; Receptors, Dopamine D2; Receptors, Dopamine D3

2011